Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Guillermo Moreno-Sanz"'
Autor:
Juan F. Galvez-Florez, Hernan F. Guillen-Burgos, Camilo A. Flórez-Puentes, Cristian E. Navarro, Guillermo Moreno-Sanz
Publikováno v:
Medical Cannabis and Cannabinoids, Pp 1-26 (2024)
Introduction: Preclinical and clinical evidence has elucidated that cannabis based medical formulations (CBMFs) may display anxiolytic, anti-depressive, and neuro-protective properties. CBMFs are often considered as novel therapeutic anxiolytic agent
Externí odkaz:
https://doaj.org/article/494b06f314a44d578d4ed9e8a42c7eb2
Publikováno v:
Medical Cannabis and Cannabinoids, Vol 7, Iss 1, Pp 149-159 (2024)
Introduction: Approximately 4% of the UK population experiences PTSD. Individuals must exhibit symptoms across four clusters to receive a diagnosis: intrusion, avoidance, altered reactivity, and altered mood. Evidence suggests that cannabinoid agonis
Externí odkaz:
https://doaj.org/article/9d15042bc6a2410889e6b7420a436883
Autor:
Guillermo Moreno-Sanz, Alvaro Madiedo, Paula Hernandez, Janosch Kratz, Oier Aizpurua-Olaizola, Matthew R. D. Brown, Juan R. López, Jorge Patiño, Fredy O. Mendivelso
Publikováno v:
Frontiers in Pain Research, Vol 3 (2022)
To date, the therapeutic use of cannabinoids in chronic pain management remains controversial owing to the limited clinical evidence found in randomized clinical trials (RCTs), the heterogeneous nature of the clinical indication, and the broad range
Externí odkaz:
https://doaj.org/article/c5634136f2944a48b207d56de9bcc026
Autor:
Waseem Sultan, Anup Mathew, Matthew R. D. Brown, Juan F. Gálvez-Flórez, Guillermo Moreno-Sanz
Publikováno v:
Brain Sciences, Vol 12, Iss 11, p 1467 (2022)
Emotionally unstable personality disorder (EUPD) is a common mental health disorder, manifesting with a range of chronic and debilitating symptoms, including impaired social functioning, unstable mood, and risky impulsive or self-injurious behaviour.
Externí odkaz:
https://doaj.org/article/95d5587fdcb44464a58cca90daea0098
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2576 (2022)
In November 2018, the UK’s Home Office established a legal route for eligible patients to be prescribed cannabis-based products for medicinal use in humans (CBPMs) as unlicensed medicines. These include liquid cannabis extracts for oral administrat
Externí odkaz:
https://doaj.org/article/280b6732e8e646ee925273d532f9516b
Autor:
Guillermo Moreno-Sanz, Carlos Ferreiro Vera, Carolina Sánchez-Carnerero, Xavier Nadal Roura, Verónica Sánchez de Medina Baena
Publikováno v:
Separations, Vol 7, Iss 4, p 56 (2020)
Minor cannabinoid and non-cannabinoid molecules have been proposed to significantly contribute to the pharmacological profile of cannabis extracts. Phytoplant Research has developed highly productive cannabis cultivars with defined chemotypes, as wel
Externí odkaz:
https://doaj.org/article/41446eee543244b4af81b82fa96de4f8
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Therapeutic use of cannabinoids, the main active ingredients of Cannabissativa L., is often hindered by their limited bioavailability and undesirable psychoactivity. We conducted an observational study in December 2016 and another one in February 201
Externí odkaz:
https://doaj.org/article/a73a9467bfd74a399ff54effa92a85ef
Publikováno v:
2021 IEEE Sensors.
Autor:
Carlos Ferreiro Vera, Carolina Sánchez-Carnerero, Xavier Nadal Roura, Guillermo Moreno-Sanz, Verónica Sánchez de Medina Baena
Publikováno v:
Separations, Vol 7, Iss 56, p 56 (2020)
Separations
Volume 7
Issue 4
Separations
Volume 7
Issue 4
Minor cannabinoid and non-cannabinoid molecules have been proposed to significantly contribute to the pharmacological profile of cannabis extracts. Phytoplant Research has developed highly productive cannabis cultivars with defined chemotypes, as wel
Autor:
Linda A. Parker, Cheryl L. Limebeer, Gavin N. Petrie, Erin M. Rock, Roberto Angelini, Daniele Piomelli, Guillermo Moreno-Sanz
Publikováno v:
British Journal of Pharmacology. 174:3837-3847
BACKGROUND AND PURPOSE To evaluate the ability of the peripherally restricted fatty acid amide hydrolase (FAAH) inhibitor, URB937 (cyclohexylcarbamic acid 3′–carbamoyl–6–hydroxybiphenyl–3–yl ester) to suppress acute and anticipatory nause